CJC-1295 + Ipamorelin
Dual Peptide Combination for Growth Hormone Related Receptor Signaling Research
- Third-party tested
- COA per batch
- Lyophilized research material
Description
This research combination pairs CJC-1295, a growth-hormone-releasing-hormone-related peptide analog, with Ipamorelin, a selective growth-hormone-secretagogue peptide. The combination is intended for laboratory investigation of complementary receptor-mediated endocrine signaling pathways.
$85.00/ 10 mg · USD
SKU VP-CJC-10
Get notified when 10 mg is back
This product is currently out of stock. Its specifications and certificate documentation below remain available.
Certificate published per batch
Awaiting client documentation
Purity stated per lot
Figures are reported against the lot they belong to, never as a brand average. The analysis for a batch is published on that batch’s certificate.
- Certificate published for each batch
- Third-party tested
- Orders over $200 ship free
- Supplied for laboratory research use only
Complete your protocol
Lyophilized vials are supplied dry. Add the accompanying laboratory supplies in one step.
- CJC-1295 + IpamorelinThis item
Nothing selected
$0.00
Supplied as laboratory materials for research use only.
Scientific overview
CJC-1295 is a synthetic analog derived from growth-hormone-releasing-hormone-related peptide research. It has been investigated for its interaction with the growth hormone-releasing hormone receptor and downstream endocrine signaling. Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Research has demonstrated activity through growth-hormone-secretagogue/ghrelin-receptor-related signaling. Because the compounds engage different upstream signaling systems, researchers may investigate their individual and combined effects on receptor activation and endocrine signaling.
Research applications
- GHRH receptor signaling
- Growth hormone secretagogue receptor research
- Ghrelin-receptor pathways
- Pituitary signaling models
- Endocrine peptide research
- Receptor interaction studies
- Hormone-signaling pathways
- Peptide synergy models
CJC-1295 exists in different research configurations, commonly distinguished by DAC versus non-DAC structures. The exact identity, molecular formula, molecular weight, and CAS number displayed on the viopep website should correspond to the material documented on the applicable batch COA.
Research use & regulatory disclaimer
All products offered by viopep are intended solely for laboratory research and analytical purposes. viopep products are not intended for human or veterinary use or consumption.
Products offered by viopep have not been approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition. Products are not intended to be used as drugs, food products, dietary supplements, cosmetics, or household products.
Information provided on this website is for general informational and research purposes only. Nothing on this website is intended to constitute medical advice, diagnosis, treatment recommendations, dosing instructions, or guidance regarding human or veterinary use.
By purchasing from viopep, the purchaser acknowledges that products are intended solely for legitimate research purposes and agrees to use and handle all products in accordance with applicable laws, regulations, and appropriate laboratory safety procedures.
Specifications
| Ipamorelin Type | Synthetic pentapeptide |
|---|---|
| Research Category | Endocrine & Receptor Signaling |
| Catalog strengths | 10 mg |
| SKU | VP-CJC-10 |
| Purity | Published on the certificate for each batch |
| Analytical method | Published on the certificate for each batch |
| Testing laboratory | Published on the certificate for each batch |
| Form | Lyophilized research material |
Storage and handling
Store lyophilized at -20°C; protect from light and moisture. Reconstitute with bacteriostatic water; refrigerate reconstituted solution at 2-8°C.
